AHA: Other Defibrillation Strategies Studied for Refractory V-Fib

WEDNESDAY, Nov. 9, 2022 (HealthDay News) -- For patients with refractory ventricular fibrillation during out-of-hospital cardiac arrest, use of double sequential external defibrillation (DSED) or vector-change (VC) defibrillation results in better survival to hospital discharge compared with standard defibrillation, according to a study published online Nov. 6 in the New England Journal of Medicine to coincide with the American Heart Association Scientific Sessions 2022, held from Nov. 5 to 7 in Chicago.
Sheldon Cheskes, M.D., from the University of Toronto, and colleagues conducted a cluster-randomized trial among six Canadian paramedic services to assess DSED and VC defibrillation compared to standard defibrillation in adults with refractory ventricular fibrillation during out-of-hospital cardiac arrest. Data were included for 405 patients: 136, 144, and 125 were randomly assigned to receive standard defibrillation, VC defibrillation, and DSED, respectively. The data and safety monitoring board stopped the trial due to the coronavirus pandemic.
The researchers found that compared with the standard group, survival to hospital discharge was more common in the DSED and VC groups (30.4 and 21.7 percent, respectively, versus 13.3 percent; relative risks [95 percent confidence intervals], 2.21 [1.33 to 3.67] and 1.71 [1.01 to 2.88], respectively). A higher percentage of patients had a good neurologic outcome with DSED but not VC defibrillation compared with standard defibrillation (relative risks [95 percent confidence intervals], 2.21 [1.26 to 3.88] and 1.48 [0.81 to 2.71], respectively).
"Although the outcomes favored DSED, the logistics of having a second defibrillator available may be a challenge in some paramedic services," the authors write.
One author disclosed financial ties to ZOLL Medical.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
Las tasas de violencia con armas de fuego de EE. UU. aumentaron en un 30 por ciento durante la pandemia
VIERNES, 22 de octubre 2021 (HealthDay News) -- La violencia con armas de fuego...
Beneficial Effects of Salt Substitutes on BP Are Consistent
WEDNESDAY, Aug. 10, 2022 (HealthDay News) -- The beneficial effects of salt...
Peanut Oral Immunotherapy Effective for Children Under 12 Months
MONDAY, Aug. 14, 2023 (HealthDay News) -- Peanut oral immunotherapy (OIT) can...
Hyponatremia Hospitalizations Up With Rising Ambient Temps
TUESDAY, March 15, 2022 (HealthDay News) -- The incidence of hyponatremia...